15 Of Top 20 Biopharma Companies By Revenue Report 5.2% YoY Growth In 2022
The biopharmaceutical industry had an exceptional year in 2022 with notable success for those with COVID-19 vaccines. The majority (15) … Read more
The biopharmaceutical industry had an exceptional year in 2022 with notable success for those with COVID-19 vaccines. The majority (15) … Read more
Key Points Shares of Caribou Biosciences (NASDAQ:CRBU) were up 45% yesterday after Pfizer (NYSE:PFE) made a $25 million equity investment. … Read more
Key Points Pfizer (NYSE:PFE) was expected to post a significant decline in revenue and earnings because of the slowing COVID … Read more
BioNTech had a strong quarter despite slowing COVID sales. A robust pipeline makes it a takeover target for larger pharma … Read more
Pfizer is merging with Seagen in a $43 billion acquisition. Seagen was a sought-after target and Pfizer is succeeding where … Read more
After a sub-par performance in 2021, healthcare stocks outperformed the S&P 500 in 2022. As well, 2023 is expected to … Read more
The stock market finished January on a positive note. This is a good sign for investors, who incurred huge losses … Read more
The fourth quarter earnings season for the S&P 500 didn’t get off to a strong start. So far, 11% of … Read more
Global drug spending is set to reach $1.9 trillion by 2027. Pfizer remains well-positioned to capture much of this. A … Read more
Pfizer Inc. could outperform with consistent dividend and revenue growth. Regeneron Pharmaceuticals Inc. has a high P/E with a low … Read more
Mega-cap stocks are those with a minimum market capitalization of $200 billion. Although the numbers of such stocks are limited, … Read more
Supply shortages have complicated the pharmaceutical industry. Eli Lilly & Co are making the right pivots. New partnerships aimed at … Read more
Pfizer (NYSE:PFE) is a well-known pharmaceutical company popular with dividend growth and income investors. The company has grown into one … Read more
About 20% of the S&P 500 companies have reported their earnings numbers for the third quarter 2022 as of last … Read more
Discusses the trial results, analyst commentary and Fintel platform analysis On Monday, biopharmaceutical firm Vaxcyte Inc (NASDAQ:PCVX) led the market … Read more